 | • レポートコード：QFJ1-5980 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、88ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、ラニビズマブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（使い捨てプレフィルドシリンジ、使い捨てガラスバイアル）、用途別市場規模（wAMD、糖尿病性網膜症（DR）、糖尿病性黄斑浮腫（DME）、mCNV、RVO）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ラニビズマブの市場動向 ・企業の競争状況、市場シェア ・ラニビズマブの種類別市場規模と予測2016-2027（使い捨てプレフィルドシリンジ、使い捨てガラスバイアル） ・ラニビズマブの用途別市場規模と予測2016-2027（wAMD、糖尿病性網膜症（DR）、糖尿病性黄斑浮腫（DME）、mCNV、RVO） ・ラニビズマブの北米市場規模2016-2027（アメリカ、カナダ） ・ラニビズマブの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ラニビズマブのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ラニビズマブの中南米市場規模2016-2027（メキシコ、ブラジル） ・ラニビズマブの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Genentech、Novartis） ・結論 |
Ranibizumab (trade name Lucentis among others) is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that has been approved to treat the “wet” type of age-related macular degeneration (AMD, also ARMD), a common form of age-related vision loss.
Market Analysis and Insights: Global Ranibizumab Market
The global Ranibizumab market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ranibizumab market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ranibizumab market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ranibizumab market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ranibizumab market.
Global Ranibizumab Scope and Market Size
Ranibizumab market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ranibizumab market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Single-use prefilled syringe
Single-use glass vial
Segment by Application
wAMD
Diabetic Retinopathy (DR)
Diabetic Macular Edema (DME)
mCNV
RVO
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Genentech
Novartis
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ranibizumab Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Single-use prefilled syringe
1.2.3 Single-use glass vial
1.3 Market by Application
1.3.1 Global Ranibizumab Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 wAMD
1.3.3 Diabetic Retinopathy (DR)
1.3.4 Diabetic Macular Edema (DME)
1.3.5 mCNV
1.3.6 RVO
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Ranibizumab Market Perspective (2016-2027)
2.2 Ranibizumab Growth Trends by Regions
2.2.1 Ranibizumab Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ranibizumab Historic Market Share by Regions (2016-2021)
2.2.3 Ranibizumab Forecasted Market Size by Regions (2022-2027)
2.3 Ranibizumab Industry Dynamic
2.3.1 Ranibizumab Market Trends
2.3.2 Ranibizumab Market Drivers
2.3.3 Ranibizumab Market Challenges
2.3.4 Ranibizumab Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ranibizumab Players by Revenue
3.1.1 Global Top Ranibizumab Players by Revenue (2016-2021)
3.1.2 Global Ranibizumab Revenue Market Share by Players (2016-2021)
3.2 Global Ranibizumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ranibizumab Revenue
3.4 Global Ranibizumab Market Concentration Ratio
3.4.1 Global Ranibizumab Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ranibizumab Revenue in 2020
3.5 Ranibizumab Key Players Head office and Area Served
3.6 Key Players Ranibizumab Product Solution and Service
3.7 Date of Enter into Ranibizumab Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ranibizumab Breakdown Data by Type
4.1 Global Ranibizumab Historic Market Size by Type (2016-2021)
4.2 Global Ranibizumab Forecasted Market Size by Type (2022-2027)
5 Ranibizumab Breakdown Data by Application
5.1 Global Ranibizumab Historic Market Size by Application (2016-2021)
5.2 Global Ranibizumab Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Ranibizumab Market Size (2016-2027)
6.2 North America Ranibizumab Market Size by Type
6.2.1 North America Ranibizumab Market Size by Type (2016-2021)
6.2.2 North America Ranibizumab Market Size by Type (2022-2027)
6.2.3 North America Ranibizumab Market Size by Type (2016-2027)
6.3 North America Ranibizumab Market Size by Application
6.3.1 North America Ranibizumab Market Size by Application (2016-2021)
6.3.2 North America Ranibizumab Market Size by Application (2022-2027)
6.3.3 North America Ranibizumab Market Size by Application (2016-2027)
6.4 North America Ranibizumab Market Size by Country
6.4.1 North America Ranibizumab Market Size by Country (2016-2021)
6.4.2 North America Ranibizumab Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Ranibizumab Market Size (2016-2027)
7.2 Europe Ranibizumab Market Size by Type
7.2.1 Europe Ranibizumab Market Size by Type (2016-2021)
7.2.2 Europe Ranibizumab Market Size by Type (2022-2027)
7.2.3 Europe Ranibizumab Market Size by Type (2016-2027)
7.3 Europe Ranibizumab Market Size by Application
7.3.1 Europe Ranibizumab Market Size by Application (2016-2021)
7.3.2 Europe Ranibizumab Market Size by Application (2022-2027)
7.3.3 Europe Ranibizumab Market Size by Application (2016-2027)
7.4 Europe Ranibizumab Market Size by Country
7.4.1 Europe Ranibizumab Market Size by Country (2016-2021)
7.4.2 Europe Ranibizumab Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Ranibizumab Market Size (2016-2027)
8.2 Asia-Pacific Ranibizumab Market Size by Type
8.2.1 Asia-Pacific Ranibizumab Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ranibizumab Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ranibizumab Market Size by Type (2016-2027)
8.3 Asia-Pacific Ranibizumab Market Size by Application
8.3.1 Asia-Pacific Ranibizumab Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ranibizumab Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ranibizumab Market Size by Application (2016-2027)
8.4 Asia-Pacific Ranibizumab Market Size by Region
8.4.1 Asia-Pacific Ranibizumab Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ranibizumab Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Ranibizumab Market Size (2016-2027)
9.2 Latin America Ranibizumab Market Size by Type
9.2.1 Latin America Ranibizumab Market Size by Type (2016-2021)
9.2.2 Latin America Ranibizumab Market Size by Type (2022-2027)
9.2.3 Latin America Ranibizumab Market Size by Type (2016-2027)
9.3 Latin America Ranibizumab Market Size by Application
9.3.1 Latin America Ranibizumab Market Size by Application (2016-2021)
9.3.2 Latin America Ranibizumab Market Size by Application (2022-2027)
9.3.3 Latin America Ranibizumab Market Size by Application (2016-2027)
9.4 Latin America Ranibizumab Market Size by Country
9.4.1 Latin America Ranibizumab Market Size by Country (2016-2021)
9.4.2 Latin America Ranibizumab Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ranibizumab Market Size (2016-2027)
10.2 Middle East & Africa Ranibizumab Market Size by Type
10.2.1 Middle East & Africa Ranibizumab Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ranibizumab Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ranibizumab Market Size by Type (2016-2027)
10.3 Middle East & Africa Ranibizumab Market Size by Application
10.3.1 Middle East & Africa Ranibizumab Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ranibizumab Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ranibizumab Market Size by Application (2016-2027)
10.4 Middle East & Africa Ranibizumab Market Size by Country
10.4.1 Middle East & Africa Ranibizumab Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ranibizumab Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Genentech
11.1.1 Genentech Company Details
11.1.2 Genentech Business Overview
11.1.3 Genentech Ranibizumab Introduction
11.1.4 Genentech Revenue in Ranibizumab Business (2016-2021)
11.1.5 Genentech Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Ranibizumab Introduction
11.2.4 Novartis Revenue in Ranibizumab Business (2016-2021)
11.2.5 Novartis Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Ranibizumab Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Single-use prefilled syringe
Table 3. Key Players of Single-use glass vial
Table 4. Global Ranibizumab Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Ranibizumab Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Ranibizumab Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Ranibizumab Market Share by Regions (2016-2021)
Table 8. Global Ranibizumab Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Ranibizumab Market Share by Regions (2022-2027)
Table 10. Ranibizumab Market Trends
Table 11. Ranibizumab Market Drivers
Table 12. Ranibizumab Market Challenges
Table 13. Ranibizumab Market Restraints
Table 14. Global Ranibizumab Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Ranibizumab Market Share by Players (2016-2021)
Table 16. Global Top Ranibizumab Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ranibizumab as of 2020)
Table 17. Ranking of Global Top Ranibizumab Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Ranibizumab Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Ranibizumab Product Solution and Service
Table 21. Date of Enter into Ranibizumab Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Ranibizumab Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Ranibizumab Revenue Market Share by Type (2016-2021)
Table 25. Global Ranibizumab Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Ranibizumab Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Ranibizumab Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Ranibizumab Revenue Market Share by Application (2016-2021)
Table 29. Global Ranibizumab Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Ranibizumab Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Ranibizumab Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Ranibizumab Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Ranibizumab Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Ranibizumab Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Ranibizumab Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Ranibizumab Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Ranibizumab Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Ranibizumab Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Ranibizumab Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Ranibizumab Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Ranibizumab Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Ranibizumab Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Ranibizumab Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Ranibizumab Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Ranibizumab Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Ranibizumab Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Ranibizumab Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Ranibizumab Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Ranibizumab Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Ranibizumab Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Ranibizumab Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Ranibizumab Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Ranibizumab Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Ranibizumab Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Ranibizumab Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Ranibizumab Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Ranibizumab Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Ranibizumab Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Ranibizumab Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Ranibizumab Market Size by Country (2022-2027) & (US$ Million)
Table 61. Genentech Company Details
Table 62. Genentech Business Overview
Table 63. Genentech Ranibizumab Product
Table 64. Genentech Revenue in Ranibizumab Business (2016-2021) & (US$ Million)
Table 65. Genentech Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Ranibizumab Product
Table 69. Novartis Revenue in Ranibizumab Business (2016-2021) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ranibizumab Market Share by Type: 2020 VS 2027
Figure 2. Single-use prefilled syringe Features
Figure 3. Single-use glass vial Features
Figure 4. Global Ranibizumab Market Share by Application: 2020 VS 2027
Figure 5. wAMD Case Studies
Figure 6. Diabetic Retinopathy (DR) Case Studies
Figure 7. Diabetic Macular Edema (DME) Case Studies
Figure 8. mCNV Case Studies
Figure 9. RVO Case Studies
Figure 10. Ranibizumab Report Years Considered
Figure 11. Global Ranibizumab Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Ranibizumab Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Ranibizumab Market Share by Regions: 2020 VS 2027
Figure 14. Global Ranibizumab Market Share by Regions (2022-2027)
Figure 15. Global Ranibizumab Market Share by Players in 2020
Figure 16. Global Top Ranibizumab Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ranibizumab as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Ranibizumab Revenue in 2020
Figure 18. Global Ranibizumab Revenue Market Share by Type (2016-2021)
Figure 19. Global Ranibizumab Revenue Market Share by Type (2022-2027)
Figure 20. North America Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Ranibizumab Market Share by Type (2016-2027)
Figure 22. North America Ranibizumab Market Share by Application (2016-2027)
Figure 23. North America Ranibizumab Market Share by Country (2016-2027)
Figure 24. United States Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Ranibizumab Market Share by Type (2016-2027)
Figure 28. Europe Ranibizumab Market Share by Application (2016-2027)
Figure 29. Europe Ranibizumab Market Share by Country (2016-2027)
Figure 30. Germany Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Ranibizumab Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Ranibizumab Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Ranibizumab Market Share by Region (2016-2027)
Figure 40. China Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Ranibizumab Market Share by Type (2016-2027)
Figure 48. Latin America Ranibizumab Market Share by Application (2016-2027)
Figure 49. Latin America Ranibizumab Market Share by Country (2016-2027)
Figure 50. Mexico Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Ranibizumab Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Ranibizumab Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Ranibizumab Market Share by Country (2016-2027)
Figure 56. Turkey Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Genentech Revenue Growth Rate in Ranibizumab Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Ranibizumab Business (2016-2021)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
世界の増殖糖尿病網膜症治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Proliferative Diabetic Retinopathy Therapeutics Market The global Proliferative Diabetic Retinopathy Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accu…- 世界の非感染性黄斑浮腫治療市場規模・現状・予測（2021年-2027年） Non-infectious Macular Edema Treatment refers to the treatment of Non-infectious Macular Edema by drugs or therapies such as anti-VEGF therapy, corticosteroids, immunosuppressive agents, and biological agents. The macula is a region of the center of the retina. Macular edema is the accumulation of f…
- 世界の糖尿病アッセイ市場規模・現状・予測（2021年-2027年） Diabetics cause serious damage to the heart, blood vessels, eyes, kidney and nerves. High risk of cardiac disorders associated with diabetes demands efficient testing and diagnosis options. Diabetics assays are used for diagnostics and monitoring who are at risk of developing diabetes. Market Analys…
- 増殖性糖尿病性網膜症治療法のグローバル市場調査 2019年 The global Proliferative Diabetic Retinopathy Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Proliferative Diabetic Retinopathy Therapeutics volume and value at global level, regional …
- 増殖性糖尿病性網膜症治療法のグローバル市場調査 2019年 The global Proliferative Diabetic Retinopathy Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Proliferative Diabetic Retinopathy Therapeutics volume and value at global level, regional …